Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CXA-10 DDI with Pravastatin and Vytorin in Healthy Males
NCT02547402Phase 1Completed
- Sponsor
- Complexa Therapeutics
- Start
- Dec 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 10-nitro-oleic acid in acute kidney injury (AKI), sponsored by Complexa Therapeutics. Primary endpoint: Maximum Plasma Concentration at 14 days. Started Dec 2015; status: completed.
02
Drugs
10-nitro-oleic acid
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02547402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02547402.